ZIOPHARM Oncology Inc (ZIOP)

6.10
NASDAQ : Health Care
Prev Close 6.21
Day Low/High 6.05 / 6.31
52 Wk Low/High 4.45 / 9.74
Avg Volume 1.68M
Exchange NASDAQ
Shares Outstanding 132.38M
Market Cap 822.06M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

ZIOP Makes Bullish Cross Above Critical Moving Average

ZIOP Makes Bullish Cross Above Critical Moving Average

In trading on Thursday, shares of ZIOPHARM Oncology Inc crossed above their 200 day moving average of $6.06, changing hands as high as $6.35 per share. ZIOPHARM Oncology Inc shares are currently trading up about 8.2% on the day.

Interesting ZIOP Put And Call Options For March 17th

Interesting ZIOP Put And Call Options For March 17th

Investors in ZIOPHARM Oncology Inc saw new options become available this week, for the March 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZIOP options chain for the new March 17th contracts and identified one put and one call contract of particular interest.

Allergan, Apple, Facebook: Doug Kass' Views

Allergan, Apple, Facebook: Doug Kass' Views

Doug Kass shares his thoughts on buying retail, and discusses why he's favoring the short side in a big way.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Interesting ZIOP Put And Call Options For February 2017

Interesting ZIOP Put And Call Options For February 2017

Investors in ZIOPHARM Oncology Inc saw new options begin trading this week, for the February 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZIOP options chain for the new February 2017 contracts and identified one put and one call contract of particular interest.

Facebook, Apple, Starbucks: Doug Kass' Views

Facebook, Apple, Starbucks: Doug Kass' Views

Doug Kass shares his thoughts on managing and selecting short-term trades.

First Week of July 2017 Options Trading For ZIOPHARM Oncology (ZIOP)

First Week of July 2017 Options Trading For ZIOPHARM Oncology (ZIOP)

Investors in ZIOPHARM Oncology Inc saw new options begin trading this week, for the July 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Bullish and Bearish Chart Reversals

What stocks have changed direction in the past week.

ZIOPHARM Reports Third Quarter 2016 Financial Results And Provides Update On Recent Activities

ZIOPHARM Reports Third Quarter 2016 Financial Results And Provides Update On Recent Activities

Company to Host Conference Call on Thursday, November 17, 2016 at 8:00 am ET to Discuss Updated Data from Phase 1 Study of Ad-RTS-hIL-12 + Veledimex in Brain Cancer Presented at SNO 2016 Annual Meeting

First Week of December 16th Options Trading For ZIOPHARM Oncology (ZIOP)

First Week of December 16th Options Trading For ZIOPHARM Oncology (ZIOP)

Investors in ZIOPHARM Oncology Inc saw new options become available this week, for the December 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZIOP options chain for the new December 16th contracts and identified one put and one call contract of particular interest.

Noteworthy Thursday Option Activity: ZIOP, XON, SAM

Noteworthy Thursday Option Activity: ZIOP, XON, SAM

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ZIOPHARM Oncology Inc , where a total volume of 30,312 contracts has been traded thus far today, a contract volume which is representative of approximately 3.0 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 211.1% of ZIOP's average daily trading volume over the past month, of 1.4 million shares.

Ziopharm Breast Cancer Gene Therapy Tied to 'Higher Than Expected' Toxicity

Ziopharm Breast Cancer Gene Therapy Tied to 'Higher Than Expected' Toxicity

Six of nine breast cancer patients treated with an experimental gene therapy from Ziopharm Oncology ZIOP experienced a potentially dangerous immune system-related toxicity known as cytokine release syndrome.

ZIOPHARM Presents Data Demonstrating Activation Of Anti-Tumor Immune Response Using Ad-RTS-hIL-12 In Patients With Advanced Breast Cancer

ZIOPHARM Presents Data Demonstrating Activation Of Anti-Tumor Immune Response Using Ad-RTS-hIL-12 In Patients With Advanced Breast Cancer

Results Presented at the European Society for Medical Oncology (ESMO) 2016 Congress

5 Stocks Under $10 Poised for Big Breakouts

These under-$10 stocks are within range of triggering breakout trades. Here's how to trade them from here.

First Week of November 18th Options Trading For ZIOPHARM Oncology (ZIOP)

First Week of November 18th Options Trading For ZIOPHARM Oncology (ZIOP)

Investors in ZIOPHARM Oncology Inc saw new options become available this week, for the November 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZIOP options chain for the new November 18th contracts and identified one put and one call contract of particular interest.

ZIOP January 2019 Options Begin Trading

ZIOP January 2019 Options Begin Trading

Investors in ZIOPHARM Oncology Inc saw new options become available today, for the January 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 858 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

ZIOP April 2017 Options Begin Trading

ZIOP April 2017 Options Begin Trading

Investors in ZIOPHARM Oncology Inc saw new options begin trading today, for the April 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Ziopharm Oncology (ZIOP) Stock Advances After Q2 Results, Upgrade

Ziopharm Oncology (ZIOP) Stock Advances After Q2 Results, Upgrade

Ziopharm Oncology (ZIOP) reported stronger-than-expected results for the 2016 second quarter following Tuesday's closing bell.

ZIOPHARM Reports Second-Quarter 2016 Financial Results And Provides Update On Recent Activities

ZIOPHARM Reports Second-Quarter 2016 Financial Results And Provides Update On Recent Activities

Company to Host Conference Call at 4:30 PM ET Today

Today's Weak On High Volume Stock: ZIOPHARM Oncology (ZIOP)

Today's Weak On High Volume Stock: ZIOPHARM Oncology (ZIOP)

Trade-Ideas LLC identified ZIOPHARM Oncology (ZIOP) as a weak on high relative volume candidate

TheStreet Quant Rating: D (Sell)